Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland

BackgroundPersistence with antifibrotic medications in patients with idiopathic pulmonary fibrosis (IPF) is crucial for long-term outcomes. However, real-world data regarding treatment persistence patterns in IPF are scarce.MethodsWe conducted a post hoc analysis of two retrospective, real-world, mu...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Sebastian Majewski, Katarzyna Górska, Katarzyna B. Lewandowska, Magdalena M. Martusewicz-Boros, Małgorzata Sobiecka, Wojciech J. Piotrowski
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2025-06-01
Cyfres:	Frontiers in Pharmacology
Pynciau:	idiopathic pulmonary fibrosis IPF antifibrotic therapy pirfenidone nintedanib treatment persistence
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1586197/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!